Practical Recommendations for Reporting and Prognostic Stratification of Myelodysplastic Syndromes

Classification and prognostic risk stratification of patients with myelodysplastic syndromes (MDS) is essential for assessment and management of patients with this highly heterogeneous malignancy. Currently, MDS is typically classified into subtypes according to the 2008 World Health Organization (WHO) classification system. Prognosis can be stratified using various prognostic scoring systems. The International Prognostic Scoring System (IPSS) remains the standard and most widely used prognostic tool for adult patients with primary untreated MDS. …